Cargando…

Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers

Vaccination offers protection against severe COVID-19 caused by SARS-CoV-2 omicron but is less effective against infection. Characteristics such as serum antibody titer correlation to protection, viral abundance and clearance of omicron infection in vaccinated individuals are scarce. We present a 4-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marking, Ulrika, Havervall, Sebastian, Norin, Nina Greilert, Bladh, Oscar, Christ, Wanda, Gordon, Max, Ng, Henry, Blom, Kim, Phillipson, Mia, Mangsbo, Sara, Alm, Jessica J., Smed-Sörensen, Anna, Nilsson, Peter, Hober, Sophia, Åberg, Mikael, Klingström, Jonas, Thålin, Charlotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031702/ https://www.ncbi.nlm.nih.gov/pubmed/36949041 http://dx.doi.org/10.1038/s41467-023-36984-1

Ejemplares similares

Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
por: Blom, Kim, et al.
Publicado: (2022)

Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time
por: Havervall, Sebastian, et al.
Publicado: (2022)

Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
por: Bladh, Oscar, et al.
Publicado: (2023)

Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
por: Marking, Ulrika, et al.
Publicado: (2022)

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
por: Havervall, Sebastian, et al.
Publicado: (2022)

Point prevalence of SARS-CoV-2 infection among healthcare workers in March and June 2023 in Sweden
por: Blom, Kim, et al.
Publicado: (2023)

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
por: Havervall, Sebastian, et al.
Publicado: (2021)

7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
por: Marking, Ulrika, et al.
Publicado: (2023)

Infection Rate of SARS-CoV-2 in Asymptomatic Healthcare Workers, Sweden, June 2022
por: Blom, Kim, et al.
Publicado: (2022)

An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses
por: Mangsbo, Sara M., et al.
Publicado: (2021)

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19
por: Havervall, Sebastian, et al.
Publicado: (2021)

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
por: Havervall, Sebastian, et al.
Publicado: (2022)

Long‐term SARS‐CoV‐2‐specific and cross‐reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
por: Laurén, Ida, et al.
Publicado: (2022)

A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies
por: Mravinacova, Sara, et al.
Publicado: (2022)

Omicron breakthrough infections in vaccinated or previously infected hamsters
por: Zhou, Jie, et al.
Publicado: (2023)

Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection
por: Jiang, Xiao-Lin, et al.
Publicado: (2023)

Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study
por: Vikström, Linnea, et al.
Publicado: (2023)

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022)

Omicron breakthrough infections in patients with immune-mediated inflammatory diseases
por: Liew, Jean W, et al.
Publicado: (2022)

1467. Breakthrough Omicron Infections in Booster Vaccinated Healthcare Workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden
por: Ziegler, Louise, et al.
Publicado: (2022)

Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant
por: Lindahl, Hannes, et al.
Publicado: (2022)

Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Evolution of antibody immunity following Omicron BA.1 breakthrough infection
por: Kaku, Chengzi I., et al.
Publicado: (2022)

Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection
por: Zhu, Ka-Li, et al.
Publicado: (2023)

Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
por: Lee, Wen Shi, et al.
Publicado: (2023)

Evolution of antibody immunity following Omicron BA.1 breakthrough infection
por: Kaku, Chengzi I., et al.
Publicado: (2023)

Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
por: Pérez-Alós, Laura, et al.
Publicado: (2023)

Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance
por: Chen, Jiahui, et al.
Publicado: (2021)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Impact of monocyte‐related modulators and kidney function on mortality in hospitalized patients with COVID‐19
por: Sendic, Senka, et al.
Publicado: (2022)

“Role of kidney function and concentrations of BAFF, sPD-L1 and sCD25 on mortality in hospitalized patients with COVID-19”
por: Mansouri, Ladan, et al.
Publicado: (2022)

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
por: Rudberg, Ann-Sofie, et al.
Publicado: (2020)

Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses
por: Glans, Hedvig, et al.
Publicado: (2021)

Innate and adaptive immune responses against human Puumala virus infection: immunopathogenesis and suggestions for novel treatment strategies for severe hantavirus‐associated syndromes
por: Klingström, J., et al.
Publicado: (2019)

Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma
por: Zenlander, Robin, et al.
Publicado: (2021)

Breakthrough omicron COVID-19 infections in patients receiving the REGEN-Cov antibody combination
por: Flahault, Adrien, et al.
Publicado: (2022)

Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
por: Kared, Hassen, et al.
Publicado: (2022)

Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
por: Möhlendick, Birte, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0h8pp2bb1f68lptp9ns9n8bt3l